Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
326
-
Total 13F shares, excl. options
-
71.9M
-
Shares change
-
+6.04M
-
Total reported value, excl. options
-
$6.47B
-
Value change
-
+$536M
-
Put/Call ratio
-
0.78
-
Number of buys
-
166
-
Number of sells
-
-123
-
Price
-
$90.05
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2021
391 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2021.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 326 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.9M shares
of 106M outstanding shares and own 68.06% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.31M shares), JANUS HENDERSON GROUP PLC (7.25M shares), SANDS CAPITAL MANAGEMENT, LLC (5.36M shares), BlackRock Inc. (5.29M shares), Avoro Capital Advisors LLC (3.13M shares), FMR LLC (2.9M shares), Bank of New York Mellon Corp (2.01M shares), WELLINGTON MANAGEMENT GROUP LLP (2.01M shares), STATE STREET CORP (1.86M shares), and Casdin Capital, LLC (1.35M shares).
This table shows the top 326 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.